Your browser doesn't support javascript.
loading
Deconstructing tumor heterogeneity: the stromal perspective.
Vickman, Renee E; Faget, Douglas V; Beachy, Philip; Beebe, David; Bhowmick, Neil A; Cukierman, Edna; Deng, Wu-Min; Granneman, James G; Hildesheim, Jeffrey; Kalluri, Raghu; Lau, Ken S; Lengyel, Ernst; Lundeberg, Joakim; Moscat, Jorge; Nelson, Peter S; Pietras, Kristian; Politi, Katerina; Puré, Ellen; Scherz-Shouval, Ruth; Sherman, Mara H; Tuveson, David; Weeraratna, Ashani T; White, Richard M; Wong, Melissa H; Woodhouse, Elisa C; Zheng, Ying; Hayward, Simon W; Stewart, Sheila A.
Affiliation
  • Vickman RE; Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA.
  • Faget DV; These authors contributed equally to this work.
  • Beachy P; Department of Cell Biology and Physiology, Washington University in St. Louis, St. Louis, MO, USA.
  • Beebe D; These authors contributed equally to this work.
  • Bhowmick NA; Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA.
  • Cukierman E; Department of Biomedical Engineering, University of Wisconsin - Madison, Madison, WI, USA.
  • Deng WM; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Granneman JG; Department of Cancer Biology, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.
  • Hildesheim J; Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
  • Kalluri R; Department of Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.
  • Lau KS; National Cancer Institute, Bethesda, MD, USA.
  • Lengyel E; Department of Cancer Biology, MD Anderson Cancer Center, Houston, TX, USA.
  • Lundeberg J; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Moscat J; Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
  • Nelson PS; SciLifeLab, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Pietras K; Weill Cornell Medicine, Rockefeller University Campus, New York, NY, USA.
  • Politi K; Department of Medicine, University of Washington, Seattle, WA, USA.
  • Puré E; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Scherz-Shouval R; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
  • Sherman MH; Department of Biomedical Sciences, University of Pennsylvania, Philidelphia, PA, USA.
  • Tuveson D; Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel.
  • Weeraratna AT; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
  • White RM; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
  • Wong MH; Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Woodhouse EC; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.
  • Zheng Y; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
  • Hayward SW; National Cancer Institute, Bethesda, MD, USA.
  • Stewart SA; Department of Bioengineering, University of Washington, Seattle, WA, USA.
Oncotarget ; 11(40): 3621-3632, 2020 Oct 06.
Article in En | MEDLINE | ID: mdl-33088423
ABSTRACT
Significant advances have been made towards understanding the role of immune cell-tumor interplay in either suppressing or promoting tumor growth, progression, and recurrence, however, the roles of additional stromal elements, cell types and/or cell states remain ill-defined. The overarching goal of this NCI-sponsored workshop was to highlight and integrate the critical functions of non-immune stromal components in regulating tumor heterogeneity and its impact on tumor initiation, progression, and resistance to therapy. The workshop explored the opposing roles of tumor supportive versus suppressive stroma and how cellular composition and function may be altered during disease progression. It also highlighted microenvironment-centered mechanisms dictating indolence or aggressiveness of early lesions and how spatial geography impacts stromal attributes and function. The prognostic and therapeutic implications as well as potential vulnerabilities within the heterogeneous tumor microenvironment were also discussed. These broad topics were included in this workshop as an effort to identify current challenges and knowledge gaps in the field.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2020 Document type: Article Affiliation country: United States Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2020 Document type: Article Affiliation country: United States Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA